Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WP
551
DELISTED
Worldpay, Inc.
WP
| $23.4M | 0.04% |
611,479
+542,003
| +780% | +$21.5M |
|
552
Strategy Inc
MSTR
$48.7B
| $23.3M | 0.04% |
1,369,240
+120,170
| +10% | +$2.12M |
|
|
CMA.WS
553
DELISTED
Comerica Incorporated Ws
CMA.WS
| $23.3M | 0.04% |
1,052,356
-103,840
| -9% | -$2.04M |
|
|
AAT
554
American Assets Trust
AAT
$1.41B
| $23.2M | 0.04% |
591,166
+104,036
| +21% | +$4.22M |
|
555
IBM
IBM
$218B
| $23.2M | 0.04% |
+148,948
| New | +$23.9M |
|
|
JOY
556
DELISTED
Joy Global Inc
JOY
| $23.2M | 0.04% |
639,821
+146,309
| +30% | +$5.89M |
|
|
BAS
557
DELISTED
Basis Energy Services, Inc.
BAS
| $23.2M | 0.04% |
5,380
+1,198
| +29% | +$5.82M |
|
558
Conagra Brands
CAG
$8B
| $23.1M | 0.04% |
680,211
+631,125
| +1,286% | +$18.9M |
|
559
First Industrial Realty Trust
FR
$8.41B
| $23.1M | 0.04% |
1,233,125
-88,762
| -7% | -$1.77M |
|
|
BCR
560
DELISTED
CR Bard Inc.
BCR
| $23M | 0.04% |
134,886
-71,179
| -35% | -$12.2M |
|
|
DOC
561
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $23M | 0.04% |
1,498,376
+83,708
| +6% | +$1.39M |
|
|
ANN
562
DELISTED
ANN INC
ANN
| $23M | 0.04% |
476,328
+68,617
| +17% | +$2.96M |
|
|
OREX
563
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $23M | 0.04% |
464,530
+239,760
| +107% | +$14.3M |
|
|
HMHC
564
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $22.9M | 0.04% |
909,090
+630,869
| +227% | +$15.6M |
|
565
Post Holdings
POST
$3.73B
| $22.9M | 0.04% |
+648,541
| New | +$20M |
|
566
Bank of Montreal
BMO
$121B
| $22.9M | 0.04% |
+386,051
| New | +$24.2M |
|
567
Kinder Morgan
KMI
$69B
| $22.8M | 0.04% |
593,038
+584,758
| +7,062% | +$24.4M |
|
|
NVO
568
Novo Nordisk
NVO
$207B
| $22.8M | 0.04% |
+831,474
| New | +$23.4M |
|
569
Signet Jewelers
SIG
$3.24B
| $22.8M | 0.04% |
177,478
+110,965
| +167% | +$14.9M |
|
570
lululemon athletica
LULU
$13.9B
| $22.7M | 0.04% |
348,358
-136,420
| -28% | -$8.87M |
|
|
QTS
571
DELISTED
QTS REALTY TRUST, INC.
QTS
| $22.7M | 0.04% |
622,329
+113,282
| +22% | +$4.19M |
|
572
Copart
CPRT
$30.8B
| $22.5M | 0.04% |
5,077,856
+2,461,352
| +94% | +$11.1M |
|
|
BNCL
573
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $22.4M | 0.04% |
1,795,959
-396,122
| -18% | -$4.74M |
|
574
Ametek
AME
$55.6B
| $22.4M | 0.04% |
408,916
-125,609
| -23% | -$6.74M |
|
575
PVH
PVH
$3.55B
| $22.4M | 0.04% |
194,101
-141,958
| -42% | -$15.4M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.